This review outlines the proposed pathophysiology of protein-losing enteropathy after the Fontan operation and suggests a paradigm for its clinical management.
Answers are grounded in this paper and cite their sources.
Proposed post-Fontan PLE mechanism is hypothesis-generating; leaves open validation before any practice change.
Protein-losing enteropathy (PLE) is a poorly understood and enigmatic disease process affecting patients with single ventricle after Fontan operation. In those afflicted, PLE after Fontan operation results in significant morbidity and mortality. The pathophysiology of the disease is unknown; however, a proposed mechanism incorporates a combination of phenomena including: (1) altered hemodynamics, specifically low cardiac output; (2) increased mesenteric vascular resistance; (3) systemic inflammation; and (4) altered enterocyte basal membrane glycosaminoglycan make-up. A paradigm for the clinical management of PLE after Fontan operation is proposed.
No takes yet. Share an insight, caveat, or question.
Jack Rychik (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: